UBS cuts Carlyle to neutral on growth doubts
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
UBS downgraded Carlyle Group (NASDAQ:CG) from Buy to Neutral and cut its price target, citing diminished confidence in the firm's growth profile and its ability to hit 2028 financial objectives. UBS's fee-related earnings forecast implies a much lower compound annual growth rate than Carlyle targets, trimming 2027 and 2028 distributable earnings estimates.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.